<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Endometriosis: Treatment of infertility in females</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Endometriosis: Treatment of infertility in females</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Endometriosis: Treatment of infertility in females</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Hornstein, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William E Gibbons, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven L Young, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endometriosis, a disease characterized by ectopic endometrial implants throughout the pelvis, negatively impacts fertility. Although endometriosis impairs reproduction, it does not usually completely prevent pregnancy. A combination of surgery, superovulation with intrauterine insemination (IUI), and assisted reproductive technology (ART) can help these women conceive.</p><p>This topic will provide an approach to treatment of infertility in women with confirmed endometriosis. Other aspects of endometriosis are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7384.html" rel="external">"Endometriosis in adults: Pathogenesis, epidemiology, and clinical impact"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3282.html" rel="external">"Endometriosis: Management of ovarian endometriomas"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "women" or "patients" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.</p><p class="headingAnchor" id="H55481657"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>Endometriosis has been estimated to affect 10 to 15 percent of women of reproductive age [<a href="#rid1">1</a>]. Of women with endometriosis, 30 to 50 percent are estimated to have infertility [<a href="#rid2">2,3</a>]. Of women who present with infertility, 25 to 50 percent are estimated to also have endometriosis [<a href="#rid4">4,5</a>]. (See  <a class="medical medical_review" href="/z/d/html/5408.html" rel="external">"Female infertility: Causes"</a> and  <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">"Female infertility: Evaluation"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS OF INFERTILITY FROM ENDOMETRIOSIS</span><span class="headingEndMark"> — </span>While endometriosis is known to impair fertility [<a href="#rid6">6-8</a>], mechanisms of infertility associated with endometriosis are uncertain and likely depend, in part, on the stage of disease [<a href="#rid2">2</a>]. Endometriosis is surgically staged using the American Society of Reproductive Medicine staging system  (<a class="graphic graphic_figure graphicRef66366" href="/z/d/graphic/66366.html" rel="external">figure 1</a> and <a class="graphic graphic_form graphicRef89648" href="/z/d/graphic/89648.html" rel="external">form 1</a>). The spectrum of disease ranges from minimal presence of ectopic tissue (eg, 1 to 5 mm implants on the pelvic peritoneum) to severe anatomic distortion (deep ovarian endometriomas, major pelvic adhesions with obliteration of normal pelvic organ relationships). Mild disease appears to incite inflammatory pathways while advanced disease causes anatomic disruption in addition to the inflammatory response.</p><p class="bulletIndent1"><span class="glyph">●</span>Although stage I (minimal) or II (mild) endometriosis  (<a class="graphic graphic_figure graphicRef66366" href="/z/d/graphic/66366.html" rel="external">figure 1</a>) may be identified during an infertility evaluation, it is uncertain if early-stage disease is the cause of infertility. It is hypothesized that minimal/mild endometriosis is associated with an inflammatory response that results from overproduction of prostaglandins, metalloproteinases, cytokines, and chemokines [<a href="#rid9">9</a>], as well as macrophages and natural killer cells [<a href="#rid10">10</a>]. At least some of the inflammatory process appears to be reversed by lesion removal which suggests a cause and effect relationship between the lesions and markers of inflammation [<a href="#rid11">11</a>]. The resultant inflammatory process impairs ovarian, peritoneal, tubal, and endometrial function, and leads to defective folliculogenesis, fertilization, and/or implantation [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1">Additional support for this theory comes from studies reporting increased numbers of macrophages and cytokines in the peritoneal fluid of patients with endometriosis [<a href="#rid13">13-15</a>], and that their peritoneal fluid inhibits both sperm [<a href="#rid16">16</a>] and fallopian tube ciliary function in vitro [<a href="#rid17">17</a>]. In addition, eutopic endometrium may not function normally in women with endometriosis, which could impair implantation [<a href="#rid18">18</a>]. Progesterone resistance may also be involved and related to a reduction in the concentration of progesterone receptors and progesterone coactivators (eg, Hic-5) in the endometrium of women with endometriosis [<a href="#rid19">19</a>]. Animal studies (rodents and monkeys) show functional changes in the endometrium that are thought to reflect reduced implantation potential occur not long after induction of an endometriosis-like condition [<a href="#rid20">20,21</a>]. This data lends further credence to the idea that early-stage endometriosis may have a deleterious effect on embryo implantation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Advanced endometriosis (stage III or IV disease)  (<a class="graphic graphic_figure graphicRef66366" href="/z/d/graphic/66366.html" rel="external">figure 1</a>) is associated with distorted pelvic anatomy and adhesions. These changes can impair oocyte release or pick-up, alter sperm motility, cause disordered myometrial contractions, and impair fertilization and embryo transport [<a href="#rid8">8</a>]. The chemical and immunologic mechanisms discussed above for mild/moderate disease likely contribute as well. In a study of monkeys with experimentally induced endometriosis, the pregnancy rate was approximately 40 percent in normal controls, but only 12 percent in animals with advanced endometriosis and 0 percent if ovarian adhesions were present [<a href="#rid22">22</a>]. As a comparison, minimal endometriosis did not diminish the pregnancy rate.</p><p></p><p class="bulletIndent1">Advanced endometriosis may also negatively impact the ovarian follicles. Compared with women who have mild endometriosis or tubal factor infertility, studies on women with advanced endometriosis have reported abnormal folliculogenesis [<a href="#rid23">23</a>] and reduced fertilization potential of oocytes [<a href="#rid24">24</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h1">OUR APPROACH</span><span class="headingEndMark"> — </span>Infertility may be caused by endometriosis alone or endometriosis combined with other factors, both male and female. For patients who present with endometriosis symptoms or clinical signs on examination and infertility, we proceed with an infertility evaluation first  (<a class="graphic graphic_algorithm graphicRef111458" href="/z/d/graphic/111458.html" rel="external">algorithm 1</a>). We then assess the need to perform primary surgery for staging and treatment of endometriosis or repeat surgery to treat pain symptoms. Choice of infertility therapy is based on the combination of findings from the infertility evaluation and surgical staging.</p><p class="headingAnchor" id="H1684626066"><span class="h2">Perform infertility evaluation</span><span class="headingEndMark"> — </span>We do not assume that endometriosis is the sole cause of the infertility. Couples who present with infertility proceed with evaluation for contributing male and female factors as reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">"Female infertility: Evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/7453.html" rel="external">"Approach to the male with infertility"</a>.)</p><p class="headingAnchor" id="H8579063"><span class="h2">Assess need for endometriosis surgery</span><span class="headingEndMark"> — </span>Endometriosis is a chronic disease that requires life-long management with the goal of maximizing medical treatment and avoiding repeated surgery [<a href="#rid25">25</a>]. Primary laparoscopic surgery is indicated for staging and treating of endometriosis, improving fertility, and reducing pain. Indications for repeat surgical treatment are mainly severe recurrent pain symptoms that impair quality of life or treatment of a symptomatic endometrioma. Repeat surgery does not improve fertility.</p><p>A description of surgical techniques for treatment of endometriosis are found separately. (See  <a class="medical medical_review" href="/z/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain", section on 'Surgical procedures'</a>.)</p><p class="headingAnchor" id="H3267405219"><span class="h3">Endometriosis symptoms</span><span class="headingEndMark"> — </span>Non-infertile females with symptoms suggestive of endometriosis (eg, pain, dysmenorrhea, dyspareunia) who have not had primary surgical treatment are candidates for surgical diagnosis and resection. Examples include individuals who have had endometriosis visually diagnosed, but not treated, at a prior surgery (ie, appendectomy) or who have imaging or examination findings that are highly suggestive of endometriosis. (See  <a class="medical medical_review" href="/z/d/html/134970.html" rel="external">"Endometriosis: Clinical features, evaluation, and diagnosis"</a>.)</p><p>For women with infertility and symptoms of endometriosis, primary surgery to resect or ablate endometriosis increases postoperative pregnancy rates compared with diagnostic laparoscopy only. A meta-analysis reported that operative laparoscopy nearly doubled the live birth or ongoing pregnancy rates (57 versus 34 total live births or pregnancies over 382 surgeries, odds ratio [OR] 1.94, 95% CI 1.20-3.16) [<a href="#rid26">26</a>]. Surgical treatment consists of both resection and ablation. A description of surgical techniques for treatment of endometriosis is presented separately. (See  <a class="medical medical_review" href="/z/d/html/16673.html" rel="external">"Endometriosis: Surgical management of pelvic pain", section on 'Surgical procedures'</a>.)</p><p>For women with continued severe pain and infertility after primary resection, repeat surgery can reduce pain but does not treat infertility. The major fertility benefit of surgical therapy is achieved shortly after the first procedure, and women who do not conceive after initial surgical treatment typically have worse disease and their pregnancy success is less, regardless of repeat surgical intervention. Clinicians must balance the limited benefits of second and third operative procedures to treat pain or other symptoms against the potential risks of major surgery and the lower likelihood of improved birth rate compared with assisted reproductive technology (ART) [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">"Complications of laparoscopic surgery"</a>.)</p><p>Analysis of three observational studies that included 313 women reported lower pregnancy rates after repeat surgery compared with primary surgery for endometriosis (OR 0.44, 95% CI 0.28-0.68) [<a href="#rid28">28</a>]. In addition, the pregnancy rate for women undergoing in vitro fertilization (IVF) was similar to women undergoing repeat surgery (OR 1.51, 95% CI 0.58-3.91). Thus, for women who have failed to conceive after primary surgical resection of endometriosis, we proceed directly with infertility therapy. (See <a class="local">'Infertility therapy'</a> below.)</p><p class="headingAnchor" id="H8579264"><span class="h3">Endometrioma</span><span class="headingEndMark"> — </span>Females with infertility and an asymptomatic endometrioma typically proceed with ART [<a href="#rid29">29-35</a>]. Management of endometriomas is presented separately. (See  <a class="medical medical_review" href="/z/d/html/3282.html" rel="external">"Endometriosis: Management of ovarian endometriomas"</a>.)</p><p>Exceptions to the above include women with an endometrioma that is limiting oocyte retrieval during ART. Other indications for endometrioma resection are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3282.html" rel="external">"Endometriosis: Management of ovarian endometriomas"</a>.)</p><p class="headingAnchor" id="H3982562563"><span class="h3">Asymptomatic women</span><span class="headingEndMark"> — </span>Women with asymptomatic endometriosis do not require surgical treatment, even if the endometriosis has not been previously surgically removed. As the impact of asymptomatic endometriosis on fertility is not known, the risks associated with surgical resection are not warranted [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H55481828"><span class="h2">Infertility therapy</span><span class="headingEndMark"> — </span>Once the couple has completed an infertility evaluation and the woman has undergone laparoscopic evaluation and treatment of endometriosis, if indicated, the couple proceeds with infertility therapy. Infertility treatment is guided by the type and number of infertility factors identified during the evaluation. For women with no or reversible problems, reversible causes are treated when present, and subsequent therapy is guided by the stage of endometriosis. Women with nonreversible causes of infertility proceed directly with ART.</p><p class="headingAnchor" id="H311607934"><span class="h3">No or reversible infertility factors identified</span><span class="headingEndMark"> — </span>All potentially treatable infertility factors are first addressed. (See  <a class="medical medical_review" href="/z/d/html/5448.html" rel="external">"Female infertility: Treatments"</a> and  <a class="medical medical_review" href="/z/d/html/7452.html" rel="external">"Treatments for male infertility"</a>.)</p><p>If there are no identified causes or if the woman does not conceive after treatment of reversible causes (eg, intrauterine polyps or fibroids), subsequent infertility treatment is then based upon the surgical stage of endometriosis and patient age. Endometriosis is surgically staged using the revised American Society of Reproductive Medicine staging system. Cost, treatment availability, and patient preference also play a major role in the selection of treatment. (See  <a class="medical medical_review" href="/z/d/html/7410.html" rel="external">"Unexplained infertility"</a> and  <a class="medical medical_review" href="/z/d/html/7410.html" rel="external">"Unexplained infertility", section on 'Our approach'</a>.)</p><p class="headingAnchor" id="H79307274"><span class="h4">Minimal or mild endometriosis</span><span class="headingEndMark"> — </span>Women with stage I/II endometriosis have the options of natural conception, superovulation and intrauterine insemination (IUI), and ART, which includes in vitro fertilization (IVF) and intracytoplasmic sperm injection.</p><p>There is no consensus as to the optimal approach. ART is more effective but more costly and not always available or acceptable to the patient, while superovulation and intrauterine insemination (IUI) is less expensive, but when ineffective delays conception. While the selection of infertility treatment is based on medical indications, factors such as patient age, patient preference, procedure risk, birth rate, insurance coverage, and cost must also be considered. As an example, we would typically offer a patient younger than age 35 <a class="drug drug_general" data-topicid="9281" href="/z/d/drug information/9281.html" rel="external">clomiphene</a> superovulation and IUI because of the low risk of the treatment, low cost, and reasonable chance of conception. However, an identical patient may prefer to go directly to IVF to maximize chance of a live birth despite the higher cost and invasive technique compared with superovulation and IUI.</p><p class="bulletIndent1"><span class="glyph">●</span>For patients younger than 35 years who desire a trial of natural conception, we advise six months of timed intercourse. If conception does not occur within six months, or if the patient elects treatment, we offer mild superovulation with <a class="drug drug_general" data-topicid="9281" href="/z/d/drug information/9281.html" rel="external">clomiphene</a> citrate and IUI.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients younger than 35 years who prefer infertility treatment (rather than a trial of natural conception as above), or who do not conceive naturally, we advise proceeding with mild superovulation with <a class="drug drug_general" data-topicid="9281" href="/z/d/drug information/9281.html" rel="external">clomiphene</a> citrate (CC) or <a class="drug drug_general" data-topicid="10064" href="/z/d/drug information/10064.html" rel="external">letrozole</a> (which is not FDA approved for infertility) plus IUI. The intent of ovulation induction plus IUI is to enhance follicular development, ovulation, and luteal progesterone levels (to offset the associated progesterone resistance) while placing large numbers of motile sperm high in the reproductive tract (and thus bypassing possible cervical factors) to facilitate fertilization.</p><p></p><p class="bulletIndent1">Evidence from randomized trials shows that mild superovulation and IUI should be used together [<a href="#rid37">37</a>], and that this combined therapy improves fecundability in women with early stage endometriosis [<a href="#rid36">36,38-40</a>]. Women who do not conceive after three cycles of CC/IUI are typically referred for ART. (See  <a class="medical medical_review" href="/z/d/html/7407.html" rel="external">"Overview of ovulation induction"</a> and  <a class="medical medical_review" href="/z/d/html/7413.html" rel="external">"Procedure for intrauterine insemination (IUI) using processed sperm"</a>.)</p><p></p><p class="bulletIndent1">CC has the advantages of being an oral agent, easy to use, low-cost, and less likely to result in multiple gestation compared with gonadotropin mild superovulation [<a href="#rid41">41</a>]. Cumulative pregnancy rates of nearly 40 percent have been reported with this combination [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/7400.html" rel="external">"Ovulation induction with clomiphene citrate"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients ≥35 years of age, we often proceed with ART but also offer <a class="drug drug_general" data-topicid="9281" href="/z/d/drug information/9281.html" rel="external">clomiphene</a> if ART is not possible (eg, insurance, financial restraints). Advancing directly to ART has been shown to shorten the time to pregnancy (median time to pregnancy 8 and 11 months, respectively) [<a href="#rid43">43</a>]. In addition, ART offers the option of freezing excess embryos for future use.</p><p></p><p class="bulletIndent1">Historically, these patients were offered gonadotropin mild superovulation and IUI [<a href="#rid39">39,44,45</a>]. The use of gonadotropin/IUI has fallen out of favor because of the increased rate of multiple gestations, including a rate of twin pregnancies of up to 20 percent [<a href="#rid39">39</a>]. During ART, the number of embryos transferred into the uterus is controlled by the clinician.</p><p></p><p class="bulletIndent1">For couples who do not desire or are unable to proceed with ART, we offer three to four cycles of CC or an aromatase inhibitor such as <a class="drug drug_general" data-topicid="10064" href="/z/d/drug information/10064.html" rel="external">letrozole</a>, as clinically indicated, with IUI. The use of aromatase inhibitors in infertility therapy is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7407.html" rel="external">"Overview of ovulation induction", section on 'Gonadotropin therapy'</a> and  <a class="medical medical_review" href="/z/d/html/7407.html" rel="external">"Overview of ovulation induction", section on 'Letrozole'</a>.)</p><p></p><p>In contrast to this sequential approach, some clinicians may proceed directly to ART rather than attempt natural conception or superovulation, despite the higher cost, because at least one study has reported that superovulation does not perform better than attempted natural conception. In this retrospective cohort study of 96 women who underwent operative laparoscopy for endometriosis, 12-month cumulative pregnancy rates did not statistically differ between natural and ovarian stimulation cycles (45 versus 42 percent for stage I/II endometriosis and 20 and 10 percent for stage III/IV endometriosis) [<a href="#rid38">38</a>]. (See <a class="local">'Nonreversible infertility factors'</a> below.)</p><p class="headingAnchor" id="H55482040"><span class="h4">Moderate to severe endometriosis</span><span class="headingEndMark"> — </span>Women with surgically staged moderate (stage III) to severe (stage IV) endometriosis, including those with endometriomas, benefit from ART [<a href="#rid27">27,46-48</a>]. There does not appear to be a role for superovulation in these women unless they are unable to access or decline ART [<a href="#rid36">36,40</a>]. Repeat surgery does not improve fertility because even aggressive lysis of adhesions is accompanied by adhesion re-formation that may block normal tubal function and ovum pickup. Repeat surgery is only performed to treat persistent symptoms, such as severe pain. (See <a class="local">'Endometriosis symptoms'</a> above.)</p><p class="headingAnchor" id="H3146068303"><span class="h3">Nonreversible infertility factors</span><span class="headingEndMark"> — </span>For couples with nonreversible infertility factors (eg, significant male factor component, decreased ovarian reserve), we generally proceed directly with ART rather than less invasive treatments, such as superovulation and IUI, because ART is more likely to result in pregnancy. Other variables that impact this decision are the cost of treatment and extent of fertility coverage.</p><p class="headingAnchor" id="H3168734072"><span class="h1">INTERACTION OF ENDOMETRIOSIS AND ART</span></p><p class="headingAnchor" id="H55482106"><span class="h2">Impact of endometriosis on ART</span><span class="headingEndMark"> — </span>The impact of endometriosis on assisted reproductive technology (ART) outcomes varies by degree of disease. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage I/II disease</strong> – Stage I/II (mild) disease does not appear to negatively impact ART outcomes [<a href="#rid49">49,50</a>]. While a 2002 meta-analysis of 22 studies reported worsened in vitro fertilization (IVF) outcomes for patients with mild endometriosis compared with other infertile women [<a href="#rid51">51</a>], subsequent larger meta-analyses have consistently reported that women with minimal to mild endometriosis have similar live birth rates after IVF compared with women without endometriosis (relative risk [RR] 0.99, 95% CI 0.29-1.06 [<a href="#rid52">52</a>] and RR 0.94, 95% CI 0.84-1.06 [<a href="#rid53">53</a>]). There was approximately 50 percent overlap in the included studies [<a href="#rid52">52,53</a>]. (See  <a class="medical medical_review" href="/z/d/html/7404.html" rel="external">"In vitro fertilization: Overview of clinical issues and questions", section on 'Live birth and IVF'</a>.)</p><p></p><p class="bulletIndent1">Alternatively, the above study results may reflect changes in clinical recognition of stage I/II endometriosis owing to changing laparoscopy patterns over time rather than the disease’s clinical impact. Laparoscopy is required to diagnose stage I/II disease. When laparoscopy was routinely used in the evaluation of patients without evidence of male, tubal, uterine cavity, or ovulatory factors, endometriosis was diagnosed in 25 to 50 percent, or more, of patients with infertility [<a href="#rid4">4,5</a>]. By contrast, in the 2019 US Assisted Reproductive Technology Fertility Clinic and National Summary Report, only 7 percent of patients had endometriosis as an ART treatment indication [<a href="#rid54">54</a>]. The large reduction in endometriosis prevalence likely reflects a drop in diagnosis as laparoscopy is no longer a routine part of an infertility evaluation, which, in turn, has likely has resulted in a failure to recognize the disease in many patients with stage I/II disease. An additional confounder is that patients who were diagnosed, often because of pain symptoms, would largely have had surgery and resection of at least some of the lesions. These changes in clinical practice would clearly skew towards the null the outcome of any more recent study of stage I/II endometriosis on IVF outcomes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage III/IV disease</strong> – In contrast to mild endometriosis, the negative effects of stage III/IV disease are not as controversial. Three systematic reviews of 22 [<a href="#rid51">51</a>], 27 [<a href="#rid55">55</a>], and 36 [<a href="#rid53">53</a>] studies (with approximately 50 percent overlap between two of the studies [<a href="#rid53">53,55</a>]) reported lower oocyte retrieval, implantation, and pregnancy rates for women with advanced endometriosis undergoing IVF compared with women with mild endometriosis. In contrast, a much larger meta-analysis of 78 studies comprising over 20,000 women reported no difference among women with stage I/II endometriosis and stage III/IV endometriosis in live birth rate (RR 0.94, 95% CI 0.80 to 1.11) and clinical pregnancy rate (RR 0.90, 95% CI 0.82 to 1.00) [<a href="#rid52">52</a>]. However, women with advanced disease, particularly those with endometriomas, often have lower ovarian reserve and produce fewer oocytes for recovery, which reduces ART success [<a href="#rid50">50</a>]. The impact of diminished ovarian reserve becomes more pronounced in women of older age whose declining egg quality is associated with greater embryo aneuploidy. In women with poor ovarian reserve, such as those with advanced age and severe endometriosis, we discuss the option to pursue ART with donor oocytes.</p><p></p><p class="headingAnchor" id="H640152234"><span class="h2">Impact of ART on endometriosis</span><span class="headingEndMark"> — </span>There is no evidence that ART increases the recurrence of endometriosis [<a href="#rid36">36</a>]. In addition, the use of ART in women with endometriosis does not appear to increase the risk of poor birth outcome, particularly preterm birth [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H79306407"><span class="h1">INEFFECTIVE THERAPY</span><span class="headingEndMark"> — </span>Medical therapy, including hormonal suppression, Chinese herbal medicine, nutritional supplements, and complementary/alternative medicine have not been shown to improve pregnancy rates in women with endometriosis-related infertility [<a href="#rid36">36,57,58</a>]. Randomized clinical trials consistently report that hormone therapy with agents such as <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a> or gonadotropin-releasing hormone agonists for suppression of endometriosis does not improve fertility or pregnancy rates [<a href="#rid36">36,59-63</a>]. The lack of improvement applies to women treated with medical therapy alone, as well as those treated with combined medical and surgical therapy versus surgery alone. In contrast, for women whose treatment goal is pain reduction, hormonal suppression is an effective treatment. (See  <a class="medical medical_review" href="/z/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain"</a>.)</p><p class="headingAnchor" id="H61270984"><span class="h1">FERTILITY PRESERVATION</span><span class="headingEndMark"> — </span>As endometriosis can be associated with ovarian depletion and infertility, fertility preservation therapies such as embryo, oocyte, and ovarian tissue freezing have been proposed for women diagnosed with endometriosis [<a href="#rid64">64</a>]. These technologies, especially embryo and oocyte freezing, have proven efficacy for women planning treatment with gonadotoxic medications, such as chemotherapy. (See  <a class="medical medical_review" href="/z/d/html/7440.html" rel="external">"Fertility and reproductive hormone preservation: Overview of care prior to gonadotoxic therapy or surgery", section on 'Fertility preservation'</a>.)</p><p>However, offering all women diagnosed with endometriosis additional fertility preservation treatment would be extremely expensive and place a significant strain on global health care costs without providing a clear advantage, as many of these women will conceive without intervention or with a combination of the treatments reviewed above. Women who may benefit from this approach include those with bilateral endometriomas, prior ovarian surgery, and young age at diagnosis. More data are needed before a recommendation can be made regarding fertility preservation treatment in women with endometriosis.</p><p class="headingAnchor" id="H2786534815"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109439.html" rel="external">"Society guideline links: Endometriosis"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/15431.html" rel="external">"Patient education: Endometriosis (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/2174.html" rel="external">"Patient education: Endometriosis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of infertility with endometriosis varies by the stage of the disease, with mild disease inciting inflammatory pathways and advanced disease involving anatomic disruption in addition to inflammation. (See <a class="local">'Pathogenesis of infertility from endometriosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to evaluation</strong> – For patients who present with endometriosis and infertility, we proceed with an infertility evaluation. We do not assume the endometriosis is the cause of infertility. We then assess the need to perform primary endometriosis surgery. (See <a class="local">'Our approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with significant symptoms suggestive of endometriosis (eg, pain, dysmenorrhea, dyspareunia) who have not had primary surgical treatment, we recommend operative laparoscopy with ablation or excision of endometriosis implants as the first step in management after the infertility evaluation is complete (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). Operative treatment is associated with improved pregnancy rates and reduced pain symptoms compared with diagnostic surgery alone. (See <a class="local">'Endometriosis symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients who have previously undergone primary surgical treatment of endometriosis, we suggest not repeating surgical removal of endometriosis for the treatment of infertility unless there is significant pain (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Repeat surgery does not improve fertility, although it can reduce pain. Thus, clinicians must balance the limited benefits of second and third operative procedures to treat pain or other symptoms against the potential risks of major surgery and the lower likelihood of improved birth rate compared with assisted reproductive technology (ART). (See <a class="local">'Endometriosis symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with infertility and an asymptomatic presumed endometrioma, we generally proceed with ART and observation of the endometrioma rather than surgical removal. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See <a class="local">'Endometrioma'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/3282.html" rel="external">"Endometriosis: Management of ovarian endometriomas"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with endometriosis who have no symptoms other than infertility, surgical treatment to improve fertility is not indicated, even if the endometriosis has not been previously removed. As the impact of asymptomatic endometriosis on fertility is not known, the risks associated with surgical resection are not warranted. (See <a class="local">'Asymptomatic women'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infertility treatment</strong> – Infertility therapy is guided by the combination of findings from the infertility evaluation and surgical staging of endometriosis as well as patient age. Cost and patient preferences also play a major role in treatment decisions. (See <a class="local">'Infertility therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with no or reversible infertility factors, minimal to mild endometriosis (stage I/II), and age younger than 35 years are usually offered a trial of natural conception or continued infertility treatment with superovulation and intrauterine insemination (IUI). For women ≥35 years of age with stage I/II endometriosis, we often proceed directly with ART because of the shortened time to pregnancy. (See <a class="local">'Minimal or mild endometriosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with no or reversible infertility factors and/or those with advanced endometriosis (stage III/IV) are suggested to proceed directly with ART, typically in vitro fertilization when available. (See <a class="local">'Moderate to severe endometriosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with nonreversible infertility factors (eg, significant male factor component, decreased ovarian reserve), we generally proceed directly with ART, including in vitro fertilization, rather than less invasive treatments because ART is more likely to result in pregnancy. (See <a class="local">'Nonreversible infertility factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of endometriosis on assisted reproductive technology</strong> – The impact of endometriosis on ART outcomes is variable. The effects of mild endometriosis (ie, stage I/II disease) on ART are controversial. By contrast, there is consensus that stage III/IV disease can negatively impact outcomes, with one important mechanism being decreased ovarian reserve. (See <a class="local">'Impact of endometriosis on ART'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med 2001; 345:266.</a></li><li><a class="nounderline abstract_t">Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012; 39:535.</a></li><li><a class="nounderline abstract_t">Prescott J, Farland LV, Tobias DK, et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod 2016; 31:1475.</a></li><li><a class="nounderline abstract_t">Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA 2003; 290:1767.</a></li><li><a class="nounderline abstract_t">Tanahatoe SJ, Hompes PG, Lambalk CB. Investigation of the infertile couple: should diagnostic laparoscopy be performed in the infertility work up programme in patients undergoing intrauterine insemination? Hum Reprod 2003; 18:8.</a></li><li><a class="nounderline abstract_t">Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364:1789.</a></li><li><a class="nounderline abstract_t">Farquhar C. Endometriosis. BMJ 2007; 334:249.</a></li><li><a class="nounderline abstract_t">Holoch KJ, Lessey BA. Endometriosis and infertility. Clin Obstet Gynecol 2010; 53:429.</a></li><li><a class="nounderline abstract_t">Bulun SE. Endometriosis. N Engl J Med 2009; 360:268.</a></li><li><a class="nounderline abstract_t">Thiruchelvam U, Wingfield M, O'Farrelly C. Natural Killer Cells: Key Players in Endometriosis. Am J Reprod Immunol 2015; 74:291.</a></li><li><a class="nounderline abstract_t">Monsanto SP, Edwards AK, Zhou J, et al. Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients. Fertil Steril 2016; 105:968.</a></li><li><a class="nounderline abstract_t">Gupta S, Goldberg JM, Aziz N, et al. Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 2008; 90:247.</a></li><li><a class="nounderline abstract_t">Haney AF, Muscato JJ, Weinberg JB. Peritoneal fluid cell populations in infertility patients. Fertil Steril 1981; 35:696.</a></li><li><a class="nounderline abstract_t">Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987; 156:783.</a></li><li><a class="nounderline abstract_t">Fakih H, Baggett B, Holtz G, et al. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987; 47:213.</a></li><li><a class="nounderline abstract_t">Oral E, Arici A, Olive DL, Huszar G. Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: the role of seminal fluid components. Fertil Steril 1996; 66:787.</a></li><li><a class="nounderline abstract_t">Lyons RA, Djahanbakhch O, Saridogan E, et al. Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. Lancet 2002; 360:1221.</a></li><li><a class="nounderline abstract_t">Lessey BA, Castelbaum AJ, Sawin SW, et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994; 79:643.</a></li><li><a class="nounderline abstract_t">Aghajanova L, Velarde MC, Giudice LC. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinology 2009; 150:3863.</a></li><li><a class="nounderline abstract_t">Joshi NR, Miyadahira EH, Afshar Y, et al. Progesterone Resistance in Endometriosis Is Modulated by the Altered Expression of MicroRNA-29c and FKBP4. J Clin Endocrinol Metab 2017; 102:141.</a></li><li><a class="nounderline abstract_t">Kim TH, Young SL, Sasaki T, et al. Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium. J Clin Endocrinol Metab 2022; 107:788.</a></li><li><a class="nounderline abstract_t">Schenken RS, Asch RH, Williams RF, Hodgen GD. Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles, luteal phase defects, pelvic adhesions, and spontaneous abortions. Fertil Steril 1984; 41:122.</a></li><li><a class="nounderline abstract_t">Toya M, Saito H, Ohta N, et al. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril 2000; 73:344.</a></li><li><a class="nounderline abstract_t">Pal L, Shifren JL, Isaacson KB, et al. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer. J Assist Reprod Genet 1998; 15:27.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 2014; 101:927.</a></li><li><a class="nounderline abstract_t">Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 2014; :CD011031.</a></li><li><a class="nounderline abstract_t">Rizk B, Turki R, Lotfy H, et al. Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? Facts Views Vis Obgyn 2015; 7:109.</a></li><li><a class="nounderline abstract_t">Vercellini P, Somigliana E, Viganò P, et al. The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review. Acta Obstet Gynecol Scand 2009; 88:1074.</a></li><li><a class="nounderline abstract_t">Keyhan S, Hughes C, Price T, Muasher S. An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women. Biomed Res Int 2015; 2015:204792.</a></li><li><a class="nounderline abstract_t">Somigliana E, Benaglia L, Paffoni A, et al. Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum Reprod Update 2015; 21:486.</a></li><li><a class="nounderline abstract_t">Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009; 92:75.</a></li><li><a class="nounderline abstract_t">Benschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev 2010; :CD008571.</a></li><li><a class="nounderline abstract_t">Gupta S, Agarwal A, Agarwal R, Loret de Mola JR. Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online 2006; 13:349.</a></li><li><a class="nounderline abstract_t">Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update 2015; 21:809.</a></li><li><a class="nounderline abstract_t">de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010; 376:730.</a></li><li><a class="nounderline abstract_t">Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29:400.</a></li><li><a class="nounderline abstract_t">Arici A, Byrd W, Bradshaw K, et al. Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertil Steril 1994; 61:314.</a></li><li><a class="nounderline abstract_t">Gandhi AR, Carvalho LF, Nutter B, Falcone T. Determining the fertility benefit of controlled ovarian hyperstimulation with intrauterine insemination after operative laparoscopy in patients with endometriosis. J Minim Invasive Gynecol 2014; 21:101.</a></li><li><a class="nounderline abstract_t">Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med 1999; 340:177.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril 2012; 98:591.</a></li><li><a class="nounderline abstract_t">Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med 2015; 373:1230.</a></li><li><a class="nounderline abstract_t">Dickey RP, Taylor SN, Lu PY, et al. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril 2002; 78:1088.</a></li><li><a class="nounderline abstract_t">Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010; 94:888.</a></li><li><a class="nounderline abstract_t">Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; :CD004635.</a></li><li><a class="nounderline abstract_t">Peeraer K, Debrock S, De Loecker P, et al. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial. Hum Reprod 2015; 30:1079.</a></li><li><a class="nounderline abstract_t">Nesbitt-Hawes EM, Campbell N, Maley PE, et al. The Surgical Treatment of Severe Endometriosis Positively Affects the Chance of Natural or Assisted Pregnancy Postoperatively. Biomed Res Int 2015; 2015:438790.</a></li><li><a class="nounderline abstract_t">Vercellini P, Fedele L, Aimi G, et al. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod 2006; 21:2679.</a></li><li><a class="nounderline abstract_t">Bianchi PH, Pereira RM, Zanatta A, et al. Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates. J Minim Invasive Gynecol 2009; 16:174.</a></li><li><a class="nounderline abstract_t">Gibbons WE. Management of endometriosis in fertility patients. Fertil Steril 2004; 81:1204.</a></li><li><a class="nounderline abstract_t">Maignien C, Santulli P, Gayet V, et al. Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol 2017; 216:280.e1.</a></li><li><a class="nounderline abstract_t">Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002; 77:1148.</a></li><li><a class="nounderline abstract_t">Barbosa MA, Teixeira DM, Navarro PA, et al. Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44:261.</a></li><li><a class="nounderline abstract_t">Hamdan M, Omar SZ, Dunselman G, Cheong Y. Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet Gynecol 2015; 125:79.</a></li><li class="breakAll">Centers for Disease Control and Prevention. 2019 Assisted Reproductive Technology Fertility Clinic and National Summary Reort. US Dept of Health and Human Services; 2021. https://www.cdc.gov/art/reports/2019/pdf/2019-report-art-fertility-clinic-national-summary-h.pdf (Accessed on February 01, 2023).</li><li><a class="nounderline abstract_t">Harb HM, Gallos ID, Chu J, et al. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG 2013; 120:1308.</a></li><li><a class="nounderline abstract_t">Benaglia L, Candotti G, Papaleo E, et al. Pregnancy outcome in women with endometriosis achieving pregnancy with IVF. Hum Reprod 2016; 31:2730.</a></li><li><a class="nounderline abstract_t">Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2014; :CD009590.</a></li><li><a class="nounderline abstract_t">Hughes E, Brown J, Collins JJ, et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2007; :CD000155.</a></li><li><a class="nounderline abstract_t">Adamson GD, Pasta DJ. Surgical treatment of endometriosis-associated infertility: meta-analysis compared with survival analysis. Am J Obstet Gynecol 1994; 171:1488.</a></li><li><a class="nounderline abstract_t">Seibel MM, Berger MJ, Weinstein FG, Taymor ML. The effectivenss of danazol on subsequent fertility in minimal endometriosis. Fertil Steril 1982; 38:534.</a></li><li><a class="nounderline abstract_t">Loverro G, Carriero C, Rossi AC, et al. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. Eur J Obstet Gynecol Reprod Biol 2008; 136:194.</a></li><li><a class="nounderline abstract_t">Harrison RF, Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril 2000; 74:24.</a></li><li><a class="nounderline abstract_t">Parazzini F, Fedele L, Busacca M, et al. Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol 1994; 171:1205.</a></li><li><a class="nounderline abstract_t">Somigliana E, Viganò P, Filippi F, et al. Fertility preservation in women with endometriosis: for all, for some, for none? Hum Reprod 2015; 30:1280.</a></li></ol></div><div id="topicVersionRevision">Topic 7408 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11474666" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Treatment of endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23182559" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27141041" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A prospective cohort study of endometriosis and subsequent risk of infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14519712" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diagnosis and management of female infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12525433" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Investigation of the infertile couple: should diagnostic laparoscopy be performed in the infertility work up programme in patients undergoing intrauterine insemination?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15541453" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17272567" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20436320" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Endometriosis and infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19144942" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26104509" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Natural Killer Cells: Key Players in Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26698677" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18672121" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pathogenic mechanisms in endometriosis-associated infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7195828" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Peritoneal fluid cell populations in infertility patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3578392" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3493176" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Interleukin-1: a possible role in the infertility associated with endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8893686" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Peritoneal fluid from women with moderate or severe endometriosis inhibits sperm motility: the role of seminal fluid components.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12401250" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7519194" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Aberrant integrin expression in the endometrium of women with endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19389829" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27778641" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Progesterone Resistance in Endometriosis Is Modulated by the Altered Expression of MicroRNA-29c and FKBP4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34665857" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6420199" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles, luteal phase defects, pelvic adhesions, and spontaneous abortions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10685541" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9493063" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24630080" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Treatment of pelvic pain associated with endometriosis: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24696265" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Laparoscopic surgery for endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26177374" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19707899" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26240817" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25750209" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Risks of conservative management in women with ovarian endometriomas undergoing IVF.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18692796" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21069706" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Interventions for women with endometrioma prior to assisted reproductive technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16984764" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Impact of ovarian endometrioma on assisted reproduction outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26168799" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20801404" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Endometriosis and infertility: pathophysiology and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24435778" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : ESHRE guideline: management of women with endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8299789" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23911563" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Determining the fertility benefit of controlled ovarian hyperstimulation with intrauterine insemination after operative laparoscopy in patients with endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9895397" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22704630" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Endometriosis and infertility: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26398071" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12413999" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19531445" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16437491" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25788569" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26247022" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The Surgical Treatment of Severe Endometriosis Positively Affects the Chance of Natural or Assisted Pregnancy Postoperatively.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16790608" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19249705" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15136077" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Management of endometriosis in fertility patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27899313" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12057720" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Effect of endometriosis on in vitro fertilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24639087" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560108" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560108" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23834505" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27664955" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pregnancy outcome in women with endometriosis achieving pregnancy with IVF.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24610050" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Endometriosis: an overview of Cochrane Reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17636607" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Ovulation suppression for endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7802058" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Surgical treatment of endometriosis-associated infertility: meta-analysis compared with survival analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7128838" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The effectivenss of danazol on subsequent fertility in minimal endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17178185" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10899492" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977520" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25883035" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Fertility preservation in women with endometriosis: for all, for some, for none?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
